explore -WSS

explore

author：knowledge 2025-09-30 17:29:52 - browse：6

Photograph of an abandoned lab with empty bottle, boxes, and beakers all around. -- biotech coverage from STAT — Adobe

SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions to regenerate tissues throughout the body and turn a profit in the process, had just gone public. The company’s leadership believed they were poised for success — until everything slowly and irreversibly fell apart.

Three years later, Histogen no longer develops therapies. It has abandoned efforts to reverse baldness, replenish cartilage in achy knees, and quell infection and inflammation.

The company has no lab. It has no headquarters. It has just two employees, including a chief financial officer who also serves as secretary, CEO, and president. Histogen’s stock trades below $1 a share. And even that is coming to a close. On Thursday, the Nasdaq suspended trading of Histogen shares after determining that the company’s operations and assets are negligible, meaning the biotech is now officially a shell of its former self.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： 6 surprising facts about sugar

WSS

Prescription digital therapeutics are key to pharma’s future

This gene therapy has record $4.25 million price. It's saved children.

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

With Wegovy coverage, Medicare patients may face high costs

Steward Health Care expansion into Malta flopped

A letter from the executive editor: The 2023 STATUS List

hotspot

explore

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Steward Health Care expansion into Malta flopped

Hepatitis C has a cure — but many Americans still lack access to it

What Kate Middleton's cancer revelation might teach the world

After affirmative action ruling, medical educators look to 'holistic review'

Crowdfunding for unproven stem cell procedures spreads misinformation

Bright Health sells Medicare Advantage business to Molina

Skip the lead apron during X

In age of alternative facts, a scholarly course on calling out crap

Pregnancy ages women, but effects reverse after delivery

Wikipedia

This gene therapy has record $4.25 million price. It's saved children.

Asbestos ban is immediate, but health effects will linger for decades

Undocumented workers face uncertainty as immigration law takes effect in Florida

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Adam's Take: Intra

Biotech investment managers search for lucrative opportunities

knowledge

hotspot

entertainment

Wikipedia